The American Prospect: Biden Regulators Take Action on Hidden Pharma Monopolies
January 10, 2022 — Economic Liberties’ Advocacy & Outreach Manager Zach Freed laid out for The American Prospect why a new proposed rule from the Center for Medicare & Medicaid Services to address pharmacy DIR Fees is a bold move to rein in corporate power.
New Proposed DIR Fee Rule Is a Bold Move to Rein in Corporate Power
January 7, 2022 — In response to a new proposed rule from the Center for Medicare & Medicaid Services (CMS) that aims to address pharmacy Direct and Indirect Remuneration (DIR) Fees, the American Economic Liberties Project released the following statement.
Bipartisan Orgs Applaud Illinois Bill to Ban Non-Disclosure Agreements in Economic Development Deals
January 5, 2022 — A group of organizations from across the political spectrum applauded the introduction of the Honesty in Economic Development Act in Illinois (SB 3038) sponsored by Sen. Robert Peters and Rep. Will Guzzardi.
POLITICO Morning Tech: Patent nominee’s tech ties under scrutiny
January 4, 2022 — In POLITICO, Economic Liberties’ Senior Policy Analyst Krista Brown makes it clear that Apple’s historic market cap is just another indicator of the firm’s overwhelming market dominance.
Iowa Starting Line: Biden to Crack Down on Meatpacking Industry Price-Gouging, Monopolies
January 4, 2022 — Economic Liberties’ Senior Advisor J.D. Scholten talked with Iowa Starting Line about the Biden administration’s recent moves to break up consolidation in the meatpacking industry and bring meat prices back under control.